sildenafil medana õhukese polümeerikattega tablett
medana pharma s.a. - sildenafiil - õhukese polümeerikattega tablett - 100mg 4tk; 100mg 1tk
sildenafil medana õhukese polümeerikattega tablett
medana pharma s.a. - sildenafiil - õhukese polümeerikattega tablett - 50mg 4tk; 50mg 1tk
sildenafil medana õhukese polümeerikattega tablett
medana pharma s.a. - sildenafiil - õhukese polümeerikattega tablett - 25mg 1tk
atorvastatin umedica õhukese polümeerikattega tablett
umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 40mg 14tk; 40mg 60tk; 40mg 50tk; 40mg 10tk; 40mg 98tk; 40mg 84tk; 40mg 90tk; 40mg 20tk
atorvastatin umedica õhukese polümeerikattega tablett
umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 10mg 90tk; 10mg 500tk; 10mg 30tk; 10mg 28tk; 10mg 100tk; 10mg 20tk; 10mg 56tk; 10mg 98tk; 10mg 84tk; 10mg 50tk; 10mg 14tk
atorvastatin umedica õhukese polümeerikattega tablett
umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 80mg 56tk; 80mg 100tk; 80mg 90tk; 80mg 30tk; 80mg 60tk; 80mg 20tk; 80mg 50tk; 80mg 98tk; 80mg 200tk
atorvastatin umedica õhukese polümeerikattega tablett
umedica netherlands b.v. - atorvastatiin - õhukese polümeerikattega tablett - 20mg 28tk; 20mg 84tk; 20mg 200tk; 20mg 56tk; 20mg 98tk; 20mg 500tk; 20mg 30tk; 20mg 60tk; 20mg 100tk; 20mg 10tk; 20mg 50tk; 20mg 14tk
cilostazol win medica tablett
win medica s.a. - tsilostasool - tablett - 50mg 28tk; 50mg 14tk; 50mg 60tk; 50mg 50tk; 50mg 56tk; 50mg 98tk
cilostazol win medica tablett
win medica s.a. - tsilostasool - tablett - 100mg 7tk; 100mg 20tk; 100mg 56tk; 100mg 98tk; 100mg 50tk
aldara
viatris healthcare limited - imikvimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.